SPOTLIGHT -
Philadelphia-Much progress has been made in the development of gene therapies for retinal dystrophies during the last decade. Albert Maguire, MD
Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
EyePod: Modifier Gene Therapy: What is it?
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
Astellas receives permanent J-code for avacincaptad pegol intravitreal solution for GA
Terry Kim, MD, joining Alcon as chief medical officer and head of global medical safety